Skip to main content
NASDAQ:CARA

Cara Therapeutics SEC Filings & 10K Form

$13.38
+0.18 (+1.36 %)
(As of 05/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$12.96
$13.47
50-Day Range
$12.38
$29.19
52-Week Range
$11.80
$29.65
Volume479,660 shs
Average Volume1.05 million shs
Market Capitalization$669.70 million
P/E RatioN/A
Dividend YieldN/A
Beta1.7

SEC Filings

Cara Therapeutics (NASDAQ:CARA) SEC Filings

DateFilerForm TypeView
05/07/2021
4:09 PM
BlackRock Inc. (Filed by)
Cara Therapeutics (Subject)
Form SC 13G/A
04/29/2021
6:21 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2021
4:05 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2021
3:33 PM
Cara Therapeutics (Filer)
Form DEFA14A
04/23/2021
3:30 PM
Cara Therapeutics (Filer)
Form DEF 14A
04/01/2021
6:51 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
6:49 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
6:48 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
6:46 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
5:01 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2021
4:55 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:48 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:47 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:45 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:44 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
7:38 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2021
3:31 PM
Cara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2021
8:06 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
8:05 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
8:04 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
8:02 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:29 PM
Cara Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2021
4:02 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:41 PM
Cara Therapeutics (Subject)
FIRST MANHATTAN CO (Filed by)
Form SC 13G
02/12/2021
2:42 PM
Cara Therapeutics (Subject)
RHO Ventures VI LP (Filed by)
Form SC 13G/A
01/25/2021
4:32 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:16 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:15 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:14 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:12 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
5:44 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
5:43 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
5:42 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
5:41 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
7:35 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
6:11 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
7:32 PM
Cara Therapeutics (Issuer)
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
7:32 PM
Cara Therapeutics (Issuer)
Cara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
3:48 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2020
4:46 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4/A
11/23/2020
7:28 PM
Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2020
7:26 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
4:30 PM
Cara Therapeutics (Issuer)
VOGELBAUM MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
4:29 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
4:39 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
3:24 PM
Cara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2020
3:05 PM
Cara Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
Form SC 13G
10/22/2020
5:00 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
5:30 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2020
3:50 PM
Cara Therapeutics (Issuer)
Reilly Thomas Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2020
3:48 PM
Cara Therapeutics (Issuer)
Reilly Thomas Charles (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
4:17 PM
Cara Therapeutics (Filer)
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2020
4:22 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
3:15 PM
Cara Therapeutics (Filer)
Form 8-K/A
08/05/2020
5:20 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
3:51 PM
Cara Therapeutics (Issuer)
Shiff Susan Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
3:48 PM
Cara Therapeutics (Issuer)
Shiff Susan Ph.D. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/30/2020
6:18 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2020
6:11 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2020
5:00 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:49 PM
Cara Therapeutics (Issuer)
VOGELBAUM MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:48 PM
BAINS HARRISON M JR (Reporting)
Cara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:47 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:46 PM
Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
6:53 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
6:51 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:26 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
7:04 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
7:02 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2020
6:09 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
5:50 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
5:49 PM
Cara Therapeutics (Issuer)
Menzaghi Frederique Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
5:47 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
6:41 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2020
6:43 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2020
3:39 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2020
1:33 PM
Cara Therapeutics (Subject)
RHO Ventures VI LP (Filed by)
Form SC 13G/A
02/05/2020
4:01 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
10:26 AM
BlackRock Inc. (Filed by)
Cara Therapeutics (Subject)
Form SC 13G/A
01/14/2020
7:00 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
5:06 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:05 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
5:06 PM
Cara Therapeutics (Issuer)
Makara Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/23/2019
7:00 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
5:05 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
1:18 PM
Cara Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
12/04/2019
6:52 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:50 PM
Cara Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:49 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:47 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
8:15 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
3:42 PM
Cara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/20/2019
3:10 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
5:21 PM
Cara Therapeutics (Issuer)
Ives Jeffrey L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
5:07 PM
Cara Therapeutics (Issuer)
CHALMERS DEREK T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:05 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 5/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.